Chon-Hong Tann

Title: Chon-Hong Tann: Innovator in Nucleoside Processes

Introduction

Chon-Hong Tann is a notable inventor based in Berkeley Heights, NJ (US). He has made significant contributions to the field of nucleoside chemistry, particularly through his innovative processes that enhance the synthesis of therapeutically active compounds.

Latest Patents

Chon-Hong Tann holds a patent for a process titled "Process for producing 1-halo-2-deoxy-2-fluoroarabinofuranoside derivatives bearing protective ester groups from 1,3,5-tri-O-acylribofuranose." This patent is crucial as the 1-halo compounds produced are intermediates in the synthesis of therapeutically active nucleosidic compounds. His work in this area has the potential to impact the development of new medications.

Career Highlights

Tann is associated with Bristol-Myers Company, where he applies his expertise in nucleoside processes. His role at the company allows him to contribute to the advancement of pharmaceutical innovations. With a focus on improving synthesis methods, he plays a vital part in the research and development of new therapeutic agents.

Collaborations

Chon-Hong Tann has collaborated with esteemed colleagues such as Steven P. Brundidge and Henry G. Howell. These partnerships have fostered a collaborative environment that enhances the research and development efforts within the company.

Conclusion

Chon-Hong Tann is a distinguished inventor whose work in nucleoside processes has significant implications for the pharmaceutical industry. His contributions continue to pave the way for advancements in therapeutic compounds.